Abstract

BackgroundThe SURPRISE study is an open-label trial comparing the strategy of tocilizumab (TCZ) plus methotrexate (MTX) (ADD-ON) with the strategy of switching to TCZ (SWITCH) in Japanese rheumatoid arthritis (RA)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study)
T Takeuchi ... N Miyasaka
Annals of the Rheumatic Diseases | VOL. 72
T Takeuchi, et. al.T Takeuchi ... N Miyasaka
01 Jun 2013
AB0488 Influences of 2-Year Tocilizumab Therapy on Disease Activity, Quality of Life, Prevention of Joint Damage and Reduction of Concomitant Drugs (Prednisolone and Methotrexate) in Patients with Rheumatoid Arthritis
Y Hirano ... M Isono
Annals of the Rheumatic Diseases | VOL. 74
Y Hirano, et. al.Y Hirano ... M Isono
01 Jun 2015
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
Al-Shakarchi ... Gullick
Patient preference and adherence | VOL. 7
Al-Shakarchi, et. al. Al-Shakarchi ... Gullick
01 Jul 2013
OP0104 Tocilizumab: dose reduction or interval spacing – which proves a better tapering strategy for rheumatoid arthritis in clinical remission?
Y Urata ... K-I Furukawa
-
Y Urata, et. al.Y Urata ... K-I Furukawa
01 Jun 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis
Katerina Kachler ... Aline Bozec
Annals of the Rheumatic Diseases | VOL. -
Katerina Kachler, et. al.Katerina Kachler ... Aline Bozec
04 Jul 2024
Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus
Amy L Roberts ... Timothy J Vyse
Annals of the Rheumatic Diseases | VOL. -
Amy L Roberts, et. al.Amy L Roberts ... Timothy J Vyse
27 Jun 2024
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
Aiden Haghikia ... Dimitrios Mougiakakos
Annals of the Rheumatic Diseases | VOL. -
Aiden Haghikia, et. al.Aiden Haghikia ... Dimitrios Mougiakakos
27 Jun 2024
View more papers